AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the treatment of ovarian and breast cancer. The permission from the DCGI is for olaparib (Lynparza) tablets in the strengths of 100 mg and 150 mg, AstraZeneca Pharma India said in a BSE filing.

The tablets are a patented product of the AstraZeneca group, it added.

“The import and market permission for olaparib is a significant milestone for women in India living with platinum-sensitive relapsed ovarian cancer and BRCA-mutated HER-2 negative metastatic breast cancer, which has historically been difficulty-to-treat diseases,” AstraZeneca Pharma India MD Gagan Singh said.

Shares of AstraZeneca Pharma India today closed at Rs 1,710.30 per scrip on BSE, up 1.59 per cent from their previous close.

  • Related Posts

    Police bust illegal medicine supply racket

    New Delhi: Delhi Police’s crime branch has busted an illegal medicine supply racket in west Delhi and arrested a 47-year-old owner of a medical store who was allegedly selling restricted…

    2 medical store owners held in drug supply racket in Delhi

    Official said 3,360 Tramadol capsules, weighing around two kilogrammes, and 84 bottles of Codeine Phosphate Syrup of 100 millilitre each were seized in September last year. The anti-narcotics task force…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Police bust illegal medicine supply racket

    Police bust illegal medicine supply racket

    2 medical store owners held in drug supply racket in Delhi

    2 medical store owners held in drug supply racket in Delhi

    Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

    Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

    Ayush export declines by 7.4% in first nine months of FY 26

    Ayush export declines by 7.4% in first nine months of FY 26

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure